The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 2-(6-(3-morpholinophenoxy)-4-oxo-7-(4-(4-(trifluoromethyl)phenoxy)butanamido)quinazolin-3(4H)-yl)acetate ID: ALA4763678
PubChem CID: 162661992
Max Phase: Preclinical
Molecular Formula: C32H31F3N4O7
Molecular Weight: 640.62
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Cn1cnc2cc(NC(=O)CCCOc3ccc(C(F)(F)F)cc3)c(Oc3cccc(N4CCOCC4)c3)cc2c1=O
Standard InChI: InChI=1S/C32H31F3N4O7/c1-43-30(41)19-39-20-36-26-18-27(37-29(40)6-3-13-45-23-9-7-21(8-10-23)32(33,34)35)28(17-25(26)31(39)42)46-24-5-2-4-22(16-24)38-11-14-44-15-12-38/h2,4-5,7-10,16-18,20H,3,6,11-15,19H2,1H3,(H,37,40)
Standard InChI Key: QEXLOMXRNXSROR-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 50 0 0 0 0 0 0 0 0999 V2000
3.9339 -17.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2242 -17.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5084 -17.6108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5040 -18.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2215 -18.8524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9345 -18.4415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7912 -18.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0933 -18.3758 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.7929 -19.7706 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.0738 -19.1537 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9399 -16.4037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9388 -17.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6536 -17.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6518 -15.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3671 -16.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3705 -17.2331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0897 -17.6444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8101 -17.2271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8067 -16.3941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0829 -15.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0783 -15.1533 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5198 -15.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2206 -17.6411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2252 -15.9907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5081 -17.2252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2254 -15.1657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2356 -16.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9395 -14.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9402 -13.9336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2253 -13.5200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5083 -13.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5113 -14.7596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5120 -16.4003 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7917 -17.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2381 -17.2146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9487 -15.9749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6645 -16.3852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0793 -17.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3628 -17.6276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6504 -17.2118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7937 -13.5246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7975 -12.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0870 -12.2867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3704 -12.6961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3689 -13.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0840 -13.9385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 9 1 0
7 10 1 0
4 7 1 0
11 12 2 0
12 13 1 0
13 16 2 0
15 14 2 0
14 11 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 2 0
19 22 1 0
12 23 1 0
11 24 1 0
23 25 1 0
24 26 1 0
22 27 1 0
26 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 26 1 0
25 33 2 0
25 34 1 0
27 35 2 0
27 36 1 0
36 37 1 0
34 38 1 0
38 39 1 0
39 40 1 0
40 1 1 0
31 41 1 0
41 42 1 0
41 46 1 0
42 43 1 0
43 44 1 0
44 45 1 0
45 46 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 640.62Molecular Weight (Monoisotopic): 640.2145AlogP: 5.01#Rotatable Bonds: 11Polar Surface Area: 121.22Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.86CX Basic pKa: 4.24CX LogP: 4.12CX LogD: 4.12Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.18Np Likeness Score: -1.53
References 1. Ma Y,Yang J,Wei X,Pei Y,Ye J,Li X,Si G,Tian J,Dong Y,Liu G. (2020) Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy., 207 [PMID:32920426 ] [10.1016/j.ejmech.2020.112723 ]